ES2139596T3 - Procedimiento para el diagnostico in vitro de anomalias cromosomicas relacionadas con la enfermedad cmt1a. - Google Patents

Procedimiento para el diagnostico in vitro de anomalias cromosomicas relacionadas con la enfermedad cmt1a.

Info

Publication number
ES2139596T3
ES2139596T3 ES92909895T ES92909895T ES2139596T3 ES 2139596 T3 ES2139596 T3 ES 2139596T3 ES 92909895 T ES92909895 T ES 92909895T ES 92909895 T ES92909895 T ES 92909895T ES 2139596 T3 ES2139596 T3 ES 2139596T3
Authority
ES
Spain
Prior art keywords
probes
chromosomic
procedure
vitro diagnosis
cmt1a disease
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES92909895T
Other languages
English (en)
Inventor
Broeckhoven Christine Neur Van
Peter Neurog Lab B Raeymaekers
Jonghe Peter De
Jean-Jacques Neuropat L Martin
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Fujirebio Europe NV SA
Original Assignee
Innogenetics NV SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Innogenetics NV SA filed Critical Innogenetics NV SA
Application granted granted Critical
Publication of ES2139596T3 publication Critical patent/ES2139596T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/156Polymorphic or mutational markers
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/172Haplotypes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Analytical Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Dental Tools And Instruments Or Auxiliary Dental Instruments (AREA)

Abstract

LA INVENCION SE REFIERE A UN PROCESO PARA EL DIAGNOSTICO DE ANOMALIAS CROMOSOMALES SUSCEPTIBLE DE SER ASOCIADAS A LA ENFERMEDAD CMT1A. LA INVENCION TAMBIEN SE REFIERE A SONDAS CONCEBIDAS PARA SU USO EN ESTE PROCESO DE DIAGNOSTICO IN VITRO Y A KITS QUE CONTIENEN DICHAS SONDAS. LAS SONDAS DE LA INVENCION PUEDE CONTENER UNA SECUENCIA CONSTITUIDA DE APROXIMADAMENTE 15 NUCLEOTIDOS SUCESIVOS DE FRAGMENTO NOTI, CON EL FRAGMENTO NOTI QUE TIENE 1.2 X 106 PARES DE BASE Y QUE SE PUEDE OBTENER DIGIRIENDO ADN HUMANO DE PACIENTES CON NOTI, SEPARANDO LOS FRAGMENTOS RESULTANTES DE LA DIGESTION POR ELECTROFORESIS DE GEL DE CAMPO PULSADO E HIBRIDIZANDO LOS FRAGMENTOS RESULTANTES CON CUALQUIERA DE LAS SONDAS VA W409, EW401 O VAW412 O SUS DERIVADOS, EN APROXIMADAMENTE EL NUMERO TOTAL DE LOS NUCLEOTIDAS SUCESIVOS DEL FRAGMENTO NOTI. LAS ONDAS PERMITEN LA DETECCION DE LA DUPLICACION DE UNA PARTE DEL CROMOSOMA 17P.
ES92909895T 1991-05-07 1992-05-06 Procedimiento para el diagnostico in vitro de anomalias cromosomicas relacionadas con la enfermedad cmt1a. Expired - Lifetime ES2139596T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP91401220A EP0512181A1 (en) 1991-05-07 1991-05-07 Process for the in vitro diagnosis of chromosomal anomalies liable to be correlated with CMT1A disease

Publications (1)

Publication Number Publication Date
ES2139596T3 true ES2139596T3 (es) 2000-02-16

Family

ID=8208565

Family Applications (1)

Application Number Title Priority Date Filing Date
ES92909895T Expired - Lifetime ES2139596T3 (es) 1991-05-07 1992-05-06 Procedimiento para el diagnostico in vitro de anomalias cromosomicas relacionadas con la enfermedad cmt1a.

Country Status (10)

Country Link
US (1) US6110670A (es)
EP (2) EP0512181A1 (es)
AT (1) ATE186074T1 (es)
AU (1) AU1683192A (es)
CA (1) CA2102300A1 (es)
DE (1) DE69230221T2 (es)
DK (1) DK0584145T3 (es)
ES (1) ES2139596T3 (es)
GR (1) GR3032235T3 (es)
WO (1) WO1992019770A2 (es)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6225057B1 (en) * 1998-07-23 2001-05-01 Palleja, Zavier Estivell Duplications of human chromosome 15q24-25 and anxiety disorders, diagnostic methods for their detection
FR2808276B1 (fr) 2000-04-26 2004-04-02 Renaud Nalin Procede d'extraction indirecte de l'adn d'organismes non cultivables et adn susceptible d'etre obtenu par ledit procede
US7273698B2 (en) 2000-12-13 2007-09-25 Baylor College Of Medicine Defects in periaxin associated with myelinopathies
US8529744B2 (en) 2004-02-02 2013-09-10 Boreal Genomics Corp. Enrichment of nucleic acid targets
US10337054B2 (en) 2004-02-02 2019-07-02 Quantum-Si Incorporated Enrichment of nucleic acid targets
CA2552262C (en) 2004-02-02 2016-04-19 The University Of British Columbia Scodaphoresis and methods and apparatus for moving and concentrating particles
KR100642421B1 (ko) * 2004-07-07 2006-11-03 공주대학교 산학협력단 염색체 17p11.2-p12 지역의 중복 및 결실로 발병하는유전성 신경질환의 진단방법 및 진단키트
KR100613038B1 (ko) 2004-07-07 2006-08-16 공주대학교 산학협력단 염색체 17p11.2-p12 지역의 중복을 제외한 유전자돌연변이를 발병 원인으로 하는 CMT 질환의 진단방법및 진단키트
CA2496294A1 (en) 2005-02-07 2006-08-07 The University Of British Columbia Apparatus and methods for concentrating and separating particles such as molecules
EP2238434A4 (en) 2008-02-01 2011-06-22 Univ British Columbia METHODS AND APPARATUS FOR INTRODUCING AND RECOVERING PARTICLES
WO2010121381A1 (en) 2009-04-21 2010-10-28 The University Of British Columbia System and methods for detection of particles
CA2742327A1 (en) 2011-05-20 2012-11-20 The University Of British Columiba Systems and methods for enhanced scoda
WO2013104994A2 (en) 2012-01-13 2013-07-18 The University Of British Columbia Multiple arm apparatus and methods for separation of particles
US9512477B2 (en) 2012-05-04 2016-12-06 Boreal Genomics Inc. Biomarker anaylsis using scodaphoresis
US9340835B2 (en) 2013-03-15 2016-05-17 Boreal Genomics Corp. Method for separating homoduplexed and heteroduplexed nucleic acids
US11130986B2 (en) 2015-05-20 2021-09-28 Quantum-Si Incorporated Method for isolating target nucleic acid using heteroduplex binding proteins
KR20220101108A (ko) 2019-10-29 2022-07-19 퀀텀-에스아이 인코포레이티드 유체의 연동 펌핑 및 연관 방법, 시스템, 및 디바이스

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2226592A (en) * 1991-06-06 1993-01-08 Baylor College Of Medicine Molecular diagnosis of autosomal dominant charcot-marie-tooth disease
US5306616A (en) * 1991-06-06 1994-04-26 Baylor College Of Medicine Molecular diagnosis of autosomal dominant charcot-marie-tooth disease

Also Published As

Publication number Publication date
US6110670A (en) 2000-08-29
WO1992019770A3 (en) 1993-01-07
GR3032235T3 (en) 2000-04-27
EP0512181A1 (en) 1992-11-11
AU1683192A (en) 1992-12-21
DK0584145T3 (da) 2000-04-25
ATE186074T1 (de) 1999-11-15
DE69230221D1 (de) 1999-12-02
CA2102300A1 (en) 1992-11-08
WO1992019770A2 (en) 1992-11-12
EP0584145A1 (en) 1994-03-02
DE69230221T2 (de) 2000-05-31
EP0584145B1 (en) 1999-10-27

Similar Documents

Publication Publication Date Title
ES2139596T3 (es) Procedimiento para el diagnostico in vitro de anomalias cromosomicas relacionadas con la enfermedad cmt1a.
ES2096750T3 (es) Vectores retroviricos utiles para la terapia genica.
NO20002788D0 (no) Nye forbindelser
EA200000711A1 (ru) 11β-ГАЛОГЕН-7α-ЗАМЕЩЕННЫЕ ЭСТРАТРИЕНЫ, СПОСОБ ПОЛУЧЕНИЯ ФАРМАЦЕВТИЧЕСКИХ ПРЕПАРАТОВ, СОДЕРЖАЩИХ ЭТИ 11β-ГАЛОГЕН-7α-ЗАМЕЩЕННЫЕ ЭСТРАТРИЕНЫ, И ИХ ПРИМЕНЕНИЕ ДЛЯ ИЗГОТОВЛЕНИЯ ЛЕКАРСТВЕННЫХ СРЕДСТВ
NO307968B1 (no) Pyrazolo- og pyrrolopyridiner og farmasøytisk blanding derav
DE69027865D1 (de) ZUSAMMENSETZUNGEN enthaltend omega Conotoxin Peptide Derivate und deren Verwendung ZUR BEHANDLUNG VON ISCHÄMIE-ARTIGEN NEURONALEN SCHÄDIGUNGEN
NO833769L (no) Immunogent protein- eller peptidkompleks, fremgangsmaate for fremstilling og anvendelse herav som immunstimulerende middel og som vaksine
DK0839154T3 (da) Biologiske aktive peptider og præparater samt anvendelse deraf
ES2150496T3 (es) Cicloalquilimidazopiridinas condensadas.
CY1105653T1 (el) Στεροειδεις σαπωνινες για τη θεραπεια της νοσου alzheimer
DE60032795D1 (de) Nordihydroguaiaretinsäurederivate zur behandlung von tumoren
SE7905593L (sv) Acylderivat av karnitin och forfarande for framstellning derav
ATE190352T1 (de) Dorsalgewebe beeinflussender faktor und zusammensetzungen
DK0969822T3 (da) Bestemmelse af et organs eller vævs tilbøjelighed til cancer ved bestemmelse af dets prægningsmønster
ATE188873T1 (de) Tris-platin-komplexe
HK1002531A1 (en) New tumor diagnosing or therapeutical probe
GR1001151B (el) Νεα xρηση θειορεδοξινης
ES483661A1 (es) Procedimiento para la obtencion de derivados de 1,4-dihidro-piridina sila-sustituidos
ES2188802T3 (es) Vectores viricos de replicacion condicional y su uso.
ITRM930286A0 (it) Composizione farmaceutica per somministrazione rettale nel trattamentodi cefaleo e relativo metodo di preparazione ed impiego.
IT1284873B1 (it) Derivati stabili di ubichinolo procedimenti per la loro produzione e loro impiego farmaceutico
MXPA00010254A (es) Tratamiento de disfuncion sexual en ciertos grupos de pacientes.
HUP9801681A2 (hu) Mutáns proteinek
DE69942152D1 (de) Halter für ein chirurgisches instrument
ES2211996T3 (es) Agentes de union a receptores de acido hialuronico y su uso para el tratamiento de tumores o de reestenosis.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 584145

Country of ref document: ES